pld 180119gr_1

Peter Llewellyn-Davies
Chief Executive Officer, Chief Financial Officer

An over 25 year track record in financing activities, international M&A deals, company turnarounds, licensing transactions, in particular in healthcare industries including Wilex and Medigene (Link to CV).

> contact



Oliver Mutschlechner, Chief Development Officer,
Extended Management Board

PhD in Biochemistry/Biotechnology (Technical University Vienna). Over 20 years of experience in development of biologicals in R&D, pharma and biotech (Octapharma, Intercell, Apeiron). Positions in R&D, QC/QA, qualified person, regulatory affairs and management. Strong background in generating value by successful transition from early development to global commercialization.

> contact